BioSpace News Archive

CurePSP has awarded $300,000 in grants to four studies in the closely related diseases progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD).

The International Association for the Study of Lung Cancer (IASLC) has selected Medscape Oncology as its partner to host and manage these IASLC virtual conferences in 2020:

Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage company with expertise in protein dysregulation and a diverse pipeline of investigational therapeutics for neurodegenerative and rare peripheral amyloid diseases, today announced that in connection with hiring two new employees, the compensation committee of the Company’s board of directors granted the individuals hired by the Company,

Baudax Bio, Inc. (Nasdaq: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that the Compensation Committee of Baudax Bio’s Board of Directors approved inducement grants of stock options to purchase an aggregate of 24,000 shares of Baudax Bio’s common stock and restricted stock units covering 6,000 shares of Baudax Bio’s common stock to 3 newly-hired employees, with a grant date of September 30, 2020

Today, the U.S. Food and Drug Administration approved Opdivo (nivolumab) in combination with Yervoy (ipilimumab) for the first-line treatment of adults with malignant pleural mesothelioma that cannot be re

Akebia Therapeutics, Inc., a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted 11 newly-hired employees options to purchase an aggregate of 84,000 shares of Akebia’s common stock on September 30, 2020, as inducements material to each such employee’s entering into employment with Akebia.

Unum Group (NYSE: UNM) will release its third quarter 2020 results October 27 , at approximately 4:15 p.m. Eastern time . The earnings release and financial supplement will be available in the Investors section of the company’s website , which can be directly accessed at www.investors.unum.com . Members of Unum Group se

Assembly Biosciences, Inc. announced grants of stock options to two new employees to purchase an aggregate of 31,520 shares of the Company’s common stock with an exercise price of $17.29 per share, the closing price of Assembly’s common stock on October 1, 2020.

Bristol Myers Squibb Announces Update on CheckMate -915 Evaluating Opdivo (nivolumab) Plus Yervoy (ipilimumab) Versus Opdivo in Resected High-Risk Melanoma Patients PRINCETON, N.J.--( BUSINESS WIRE )-- Bristol Myers Squibb (NYSE: BMY) today announced results for the co-primary endpoint for CheckMate -915, a randomized Phase 3 study evaluating Opdivo (nivolumab) plus Yervoy (ipilimumab) versus Opdivo for patients who have had a complete surgical

Flexion Therapeutics, Inc. announced equity inducement grants to two new employees consisting of 3,315 restricted stock units.